Naar de inhoud
Gezondheid · Frankrijk

Dr. Didier Raoult, the famous French infectious disease specialist, creator and director of the Mediterranean University-Clinical Institute of Infectious Diseases, used chloroquine for treatment. The results of Dr. Raoult and his institute were outstanding: by the end of March, only 10 of the 2,400 people who received treatment at his institute had died. [—] For 80 years, chloroquine has been a cheap, common, safe generic. And only when it turned out that the medicine was priced at 4 cents, it was established that it couldn’t cure COVID-19 because it would potentially be too cheap and accessible. Another promising drug was remdesivir, an Ebola drug developed by Gilead Sciences. And what? On April 23rd, WHO “accidentally” posted on its website test results that showed that remdesivir was no good.

Klopt dit?

Onwaarvolgens EUvsDisinfo

EUvsDisinfo checkte deze bewering op 30 april 2020.

“disinformation”

  1. English

    Lees de factcheck bij EUvsDisinfo

Waarom het niet klopt, volgens EUvsDisinfo

  • The WHO said that no pharmaceutical products have yet been shown to be safe and effective for treating COVID-19.
  • Chloroquine and hydroxychloroquine can have serious side effects, especially at high doses or combined with other medicines, so they should not be used without a prescription and medical supervision.

In het Engels, zoals de weerlegging.

Samengevat door Factiz uit de weerlegging van EUvsDisinfo (CC BY 4.0). Lees de weerlegging

Meld een fout

Rond deze bewering

Eerst gezien
30 april 2020, southfront.org, volgens EUvsDisinfo (EEAS East StratCom Task Force)

Waar het opdook

  • Gezien bij southfront.org, volgens EUvsDisinfo (EEAS East StratCom Task Force), 30 april 2020

Verbanden

Klopt hier iets niet? Meld het per mailinfo@factiz.org

Het oordeel is van de redactie: een fout daarin meld je bij hen, via hun artikel bovenaan. Een fout in wat Factiz toevoegde, zoals de vertaling, het thema of de namen, meld je bij ons.

Gegevens van: EUvsDisinfo, European External Action Service. Licentie: EEAS legal notice: reuse is authorised, provided the source is acknowledged; snapshot: Mendeley Data yhdtkszvgp v3, CC BY 4.0.

De bronnen zijn het oordeel.